Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.62
-0.21 (-1.94%)
Sep 23, 2026, 10:58 AM EDT - Market open
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$552,465
Profits / Employee
-$330,748
Market Cap
1.75B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Stoke Therapeutics | 170 |
| Absci | 140 |
| Septerna | 123 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Nanobiotix | 100 |
NVAX News
- 13 days ago - Novavax Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 14 days ago - Novavax Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 20 days ago - Novavax to Participate in September Investor Conferences - PRNewsWire
- 26 days ago - Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season - PRNewsWire
- 26 days ago - US FDA approves updated COVID vaccines for 2026-27 season - Reuters
- 6 weeks ago - Novavax Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Novavax Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Novavax Earnings release: Q2 2026 - Filings